Evidence map›Paper›PMID 28714140›Full record

ArticleJournal of tissue engineering and regenerative medicine2018

Prevascularization of natural nanofibrous extracellular matrix for engineering completely biological three-dimensional prevascularized tissues for diverse applications.

Lijun Zhang, Zichen Qian, Mitchell Tahtinen, Shaohai Qi, Feng Zhao

Abstract read
In one paragraph

Article in Journal of tissue engineering and regenerative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Inducing Endogenous Cardiac Regeneration: Can Biomaterials Connect the Dots?Frontiers in bioengineering and biotechnology · 2020
    Review
  14. Review
  15. Emergent materials · 2019
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Lijun ZhangDepartment of Burns, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Zichen QianDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.
Mitchell TahtinenDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.
Shaohai QiDepartment of Burns, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Feng ZhaoDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, USA.ORCID 0000-0003-4138-9027
Michigan Technological University · USSun Yat-sen University · CN

Funding

Therapeutic Lymphatic Vessel RegenerationR15CA202656 · NCI · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI ZHAO, FENG · 2016 to 2016
$465k
Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wiR15HL115521 · NHLBI · MICHIGAN TECHNOLOGICAL UNIVERSITY · PI ZHAO, FENG · 2013 to 2013
$410k
NCI NIH HHS R15 CA202656NHLBI NIH HHS R15 HL115521
6 · The paper itself

Abstract

Self-sustainability after implantation is one of the critical obstacles facing large engineered tissues. A preformed functional vascular network provides an effective solution for solving the mass transportation problem. With the support of mural cells, endothelial cells (ECs) can form microvessels within engineered tissues. As an important mural cell, human mesenchymal stem cells (hMSCs) not only stabilize the engineered microvessel network, but also preserve their multi-potency when grown under optimal culture conditions. A prevascularized hMSC/extracellular matrix (ECM) sheet fabricated by the combination of hMSCs, ECs and a naturally derived nanofibrous ECM scaffold offers great opportunity for engineering mechanically strong and completely biological three-dimensional prevascularized tissues. The objective of this study was to create a prevascularized hMSC/ECM sheet by co-culturing ECs and hMSCs on a nanofibrous ECM scaffold. Physiologically low oxygen (2% O

Indexed as

Neovascularization, PhysiologicAngiogenesis Inducing AgentsCell DifferentiationCell HypoxiaCell LineageCell ProliferationExtracellular MatrixGene Expression RegulationHumansIntercellular Signaling Peptides and ProteinsMesenchymal Stem CellsMicrovesselsNanofibersOsteogenesisPermeabilityTissue EngineeringAngiogenesis Inducing AgentsIntercellular Signaling Peptides and Proteinsangiogenesisextracellular matrix scaffoldmesenchymal stem cellmicrovesselnanofibrous scaffoldprevascularization

Identifiers

PMID28714140
PMCPMC5771986
OpenAlexW2736164360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.